Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues. 2017

Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.

A small library of benzimidazole-fused pyrrolo[3,4-b]quinoline has been synthesized from readily available benzimidazole 2-carbaldehyde and various substituted arylamines in good to excellent yields utilizing an intramolecular Povarov reaction catalyzed by boron trifluoride diethyl etharate as the key final step. The compounds thus synthesized can be considered as decarbonyl analogues of the anticancer alkaloid luotonin A and were evaluated in a DNA relaxation assay for their ability to inhibit human topoisomerase I. Interestingly, two of the compounds showed a remarkable activity that is comparable to that of the standard drug camptothecin. The compounds were also evaluated for their cytotoxic effect in four highly aggressive human cancer cell lines, namely KB, MDA-MB231 (breast), LNCap (prostate), and HT1080 (fibrosarcoma). Some of the compounds obtained showed promising cytotoxicities for these four cell lines.

UI MeSH Term Description Entries
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
August 2012, Molecules (Basel, Switzerland),
Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
January 2013, Organic letters,
Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
April 2010, Cancer biotherapy & radiopharmaceuticals,
Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
August 2007, Organic & biomolecular chemistry,
Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
March 2011, Organic letters,
Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
January 2007, Bioorganic & medicinal chemistry,
Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
January 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
November 2020, Pharmaceuticals (Basel, Switzerland),
Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
December 2004, Bioorganic & medicinal chemistry,
Abdulrahman I Almansour, and Natarajan Arumugam, and Raju Suresh Kumar, and S M Mahalingam, and Samaresh Sau, and Giulia Bianchini, and J Carlos Menéndez, and Mohammad Altaf, and Hazem A Ghabbour
June 2020, Journal of Asian natural products research,
Copied contents to your clipboard!